[go: up one dir, main page]

DD222895A5 - Verfahren zur herstellung eines hypotriglyceridemisch aktiven polysaccharids - Google Patents

Verfahren zur herstellung eines hypotriglyceridemisch aktiven polysaccharids Download PDF

Info

Publication number
DD222895A5
DD222895A5 DD84265684A DD26568484A DD222895A5 DD 222895 A5 DD222895 A5 DD 222895A5 DD 84265684 A DD84265684 A DD 84265684A DD 26568484 A DD26568484 A DD 26568484A DD 222895 A5 DD222895 A5 DD 222895A5
Authority
DD
German Democratic Republic
Prior art keywords
polysaccharide
ferm
zimet
microorganism
mass
Prior art date
Application number
DD84265684A
Other languages
German (de)
English (en)
Inventor
Yasuo Kawai
Kazunaga Yazawa
Original Assignee
Advance Kaihatsu Kenkyusho
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advance Kaihatsu Kenkyusho filed Critical Advance Kaihatsu Kenkyusho
Publication of DD222895A5 publication Critical patent/DD222895A5/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/04—Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/46—Streptococcus ; Enterococcus; Lactococcus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Polymers & Plastics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Obesity (AREA)
  • Materials Engineering (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DD84265684A 1983-07-27 1984-07-26 Verfahren zur herstellung eines hypotriglyceridemisch aktiven polysaccharids DD222895A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP58135982A JPS6028401A (ja) 1983-07-27 1983-07-27 トリグリセリド低下活性多糖類

Publications (1)

Publication Number Publication Date
DD222895A5 true DD222895A5 (de) 1985-05-29

Family

ID=15164420

Family Applications (1)

Application Number Title Priority Date Filing Date
DD84265684A DD222895A5 (de) 1983-07-27 1984-07-26 Verfahren zur herstellung eines hypotriglyceridemisch aktiven polysaccharids

Country Status (12)

Country Link
US (1) US4687764A (hu)
EP (1) EP0132981B1 (hu)
JP (1) JPS6028401A (hu)
AU (1) AU563995B2 (hu)
CA (1) CA1239364A (hu)
DD (1) DD222895A5 (hu)
DE (1) DE3480217D1 (hu)
ES (1) ES534629A0 (hu)
HU (1) HU191697B (hu)
MX (1) MX7693E (hu)
PL (1) PL147734B1 (hu)
SU (1) SU1732815A3 (hu)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5927833A (ja) * 1982-08-06 1984-02-14 Advance Res & Dev Co Ltd コレステロール乃至トリグリセリド低下剤
JPS59122428A (ja) * 1982-12-28 1984-07-14 Advance Res & Dev Co Ltd コレステロ−ル低下活性蛋白質
JPS61151128A (ja) * 1984-12-24 1986-07-09 Advance Res & Dev Co Ltd コレステロ−ル低下活性ｒｎａ画分
JPS625991A (ja) * 1985-07-03 1987-01-12 Advance Res & Dev Co Ltd コレステロ−ル乃至トリグリセリド低下活性ｒｎａ画分
US5202431A (en) * 1985-07-08 1993-04-13 Fidia, S.P.A. Partial esters of hyaluronic acid
US4851521A (en) * 1985-07-08 1989-07-25 Fidia, S.P.A. Esters of hyaluronic acid
US6756361B1 (en) * 1997-10-14 2004-06-29 Nabi Enterococcus antigens and vaccines
JP2009149523A (ja) * 2006-03-01 2009-07-09 Ucc Ueshima Coffee Co Ltd 免疫賦活剤とその製造方法
CN103012615B (zh) * 2013-01-08 2015-02-25 广东海洋大学 一种高效提取乌贼墨酸性多糖的方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS52117492A (en) * 1975-12-11 1977-10-01 Hayashibara Biochem Lab Inc Preparation of water-insoluble glucan
US4251519A (en) * 1979-07-30 1981-02-17 Anheuser-Busch, Incorporated Process for the prevention and reduction of elevated blood cholesterol and triglycerides levels
JPS5943929B2 (ja) * 1979-08-13 1984-10-25 サッポロビール株式会社 多糖体ｒｂｓ物質，その製法およびそれを有効成分とする抗腫瘍性剤
JPS601877B2 (ja) * 1981-01-14 1985-01-17 明治乳業株式会社 高分子多糖類物質ｍｐｓ−８０及びその製造法
DE3305047A1 (de) * 1982-02-19 1983-09-22 Terumo Kabushiki Kaisha trading as Terumo Corp., Tokyo Polysaccharide, ihre herstellung und diese enthaltende therapeutische zusammensetzungen
JPS5927833A (ja) * 1982-08-06 1984-02-14 Advance Res & Dev Co Ltd コレステロール乃至トリグリセリド低下剤

Also Published As

Publication number Publication date
JPH0365362B2 (hu) 1991-10-11
ES8505722A1 (es) 1985-06-01
SU1732815A3 (ru) 1992-05-07
HU191697B (en) 1987-03-30
PL248970A1 (en) 1985-04-09
PL147734B1 (en) 1989-07-31
DE3480217D1 (en) 1989-11-23
AU3048884A (en) 1985-01-31
ES534629A0 (es) 1985-06-01
US4687764A (en) 1987-08-18
EP0132981A3 (en) 1986-01-29
HUT34773A (en) 1985-04-28
EP0132981A2 (en) 1985-02-13
AU563995B2 (en) 1987-07-30
EP0132981B1 (en) 1989-10-18
CA1239364A (en) 1988-07-19
MX7693E (es) 1990-08-24
JPS6028401A (ja) 1985-02-13

Similar Documents

Publication Publication Date Title
CA1246445A (en) Intestinal microflora-improving agent
EP0049847B1 (de) Alpha-Amylaseinaktivator, Verfahren zu seiner Herstellung, Mittel auf Basis dieses Inaktivators sowie dieser Inaktivator zur Regulierung des Blutzuckerspiegels
DE69226622T2 (de) Lyophilisierte Bakterien enthaltende Diät- oder Arzneimittelnzusammenstellungen
EP0101209A2 (en) Hypocholesterolemically and/or hypotriglyceridemically active products
EP0003616A2 (de) Neue Aminozucker-Derivate, ihre Herstellung und Amylase-hemmende Mittel
DE2331144A1 (de) Wasserloesliche extrakte von mycobacterien
DD215580A5 (de) Hypocholesterolaemisch aktives protein
DD222895A5 (de) Verfahren zur herstellung eines hypotriglyceridemisch aktiven polysaccharids
DE69116601T2 (de) Verfahren zur Herstellung von Antitumordextran
US5494819A (en) Pure culture of Pantoea agglomerans ferm BP-3511
DE69919302T2 (de) Immunomodulator enthaltend bakterielle Zellen oder Abbauprodukte ihrer Zellwände
DE3301997A1 (de) Verfahren zur herstellung von disaccharid-tripeptiden und disaccharid-tetrapeptiden
DE69324918T2 (de) Arznei gegen cystische fibrosen
DE60029084T2 (de) Neue depsipeptid-verbindung
GB1567106A (en) Microbial fractions
DE69029061T2 (de) Antihypertonika und Lebensmittel und Getränke, die solche Antihypertonika enthalten
CH639133A5 (de) Verfahren zur herstellung einer antitumor wirksamen substanz mit immunostimulierender wirkung.
EP0286869A1 (de) Verfahren zur Herstellung von Zellwandkomponenten aus Halobakterien und deren Verwendung als Arzneimittel
EP0173950A2 (de) Neuer alpha-Glukosidase Inhibitor, Verfahren zur seiner Herstellung, seine Verwendung und pharmazeutische Präparate
DE2950980C2 (de) Antibiotikum BN-183B und Arzneimittel, welche dieses enthalten
DE2708493A1 (de) Neues antibiotikum am-1042
CA1276897C (en) Hypocholesterolemically active rna fractions
DE3686607T2 (de) Hypocholesttrinaemisch und/oder hypotriglyceridaemisch aktive rns-fraktionen.
DE2146674C3 (de) Faktor und seine Verwendung als Arzneimittel
EP0196858A2 (en) Liver function-improving agent and blood pressure-lowering agent

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee